Alphabet Inc. Gritstone Bio, Inc. Transaction History

Alphabet Inc.

  • $1.46 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Nov 14, 2022
SELL
$2.57 - $4.22 $1.41 Million - $2.31 Million
-547,488 Closed
0 $0
Q3 2020

Nov 14, 2022
SELL
$2.63 - $8.09 $1 Million - $3.09 Million
-381,534 Reduced 41.07%
547,488 $1.45 Million
Q3 2018

Nov 14, 2022
BUY
$14.24 - $14.24 $13.2 Million - $13.2 Million
929,022 New
929,022 $13.2 Million

Others Institutions Holding GRTS

# of Institutions
62
Shares Held
35.4M
Call Options Held
395K
Put Options Held
132K
View Full List

About Gritstone bio, Inc.

GRTS Quotes by TradingView
  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Alphabet Inc. Portfolio

Follow Alphabet Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alphabet Inc., based on Form 13F filings with the SEC.

News

Stay updated on Alphabet Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email